home / stock / cmpx / cmpx quote
Last: | $3.98 |
---|---|
Change Percent: | 9.04% |
Open: | $3.65 |
Close: | $3.98 |
High: | $3.995 |
Low: | $3.995 |
Volume: | 7,020 |
Last Trade Date Time: | 11/02/2021 04:54:36 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$3.98 | $3.65 | $3.98 | $3.995 | $3.995 | 7,020 | 11-02-2021 |
$3.02 | $3 | $3.02 | $3.02 | $3 | 1,875 | 10-29-2021 |
$3 | $2.9 | $3 | $3.03 | $2.9 | 5,612 | 10-28-2021 |
$2.9 | $3 | $2.9 | $3.01 | $2.9 | 2,970 | 10-27-2021 |
$3 | $3.1325 | $3 | $3.1325 | $2.01 | 20,455 | 10-26-2021 |
$3.15 | $3.25 | $3.15 | $3.25 | $3.08 | 6,627 | 10-25-2021 |
$3.25 | $3.25 | $3.25 | $3.25 | $3.25 | 100 | 10-22-2021 |
$3.25 | $3.16 | $3.25 | $3.25 | $3.16 | 6,804 | 10-21-2021 |
$3.28 | $3.25 | $3.28 | $3.3 | $3.25 | 18,273 | 10-20-2021 |
$3.25 | $3.25 | $3.25 | $3.25 | $3.25 | 2,028 | 10-19-2021 |
$3.2 | $3.21 | $3.2 | $3.21 | $3.16 | 11,920 | 10-18-2021 |
$3.21 | $3.21 | $3.21 | $3.21 | $3.21 | 4,200 | 10-15-2021 |
$3.17 | $3.16 | $3.17 | $3.18 | $3.16 | 2,487 | 10-14-2021 |
$3.16 | $3.2 | $3.16 | $3.2 | $3.16 | 1,092 | 10-13-2021 |
$3.25 | $3.35 | $3.25 | $3.35 | $3.21 | 15,200 | 10-12-2021 |
$3.4 | $3.51 | $3.4 | $3.51 | $3.4 | 3,042 | 10-08-2021 |
$3.51 | $3.35 | $3.51 | $3.51 | $3.35 | 13,909 | 10-07-2021 |
$3.3 | $3.5 | $3.3 | $3.5 | $3.3 | 1,309 | 10-06-2021 |
$3.5 | $3.51 | $3.5 | $3.51 | $3.5 | 1,962 | 10-05-2021 |
$3.51 | $3.5 | $3.51 | $3.51 | $3.5 | 10,387 | 10-01-2021 |
News, Short Squeeze, Breakout and More Instantly...
Compass Therapeutics Inc. Company Name:
CMPX Stock Symbol:
OTCMKTS Market:
BOSTON, May 30, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (NASDAQ:CMPX), a clinical-stage, oncology-focused biopharmaceutical company ...
BOSTON, May 30, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will participate in a fireside cha...
BOSTON, May 28, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (NASDAQ:CMPX), a clinical-stage, oncology-focused biopharmaceutical company ...